An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia

Published:2020-05-20 Issue:6 Volume:26 Page:1038-1045
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Al‐Samkari Hanny¹^ORCID,Albitar Hasan A.²,Olitsky Scott E.³,Clancy Marianne S.³,Iyer Vivek N.⁴

Affiliation:

1. Division of Hematology Massachusetts General Hospital, Harvard Medical School Boston MA USA

2. Department of Internal Medicine Mayo Clinic Rochester MN USA

3. Cure HHT Monkton MD USA

4. Division of Pulmonary and Critical Care Medicine Mayo Clinic Rochester MN USA

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14034

Reference35 articles.

1. Hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease)

2. Genetic abnormalities in hereditary hemorrhagic telangiectasia

3. Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist’s perspective

4. Genotype-phenotype relationship for localization and age distribution of telangiectases in hereditary hemorrhagic telangiectasia

5. Visceral manifestations in hereditary haemorrhagic telangiectasia type 2

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How I treat bleeding in hereditary hemorrhagic telangiectasia;Blood;2024-08-29

2. Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder in women;Blood Advances;2024-06-14

3. Rare bleeding disorders: Advances in management;Haemophilia;2024-03-18

4. Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances;Journal of Clinical Investigation;2024-02-15

5. Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trial;Journal of Internal Medicine;2023-08-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3